Role of HER receptors family in development and differentiation

被引:194
作者
Casalini, P [1 ]
Iorio, MV [1 ]
Galmozzi, E [1 ]
Ménard, S [1 ]
机构
[1] Ist Nazl Tumori, Mol Targeting Unit, Dept Expt Oncol, I-20133 Milan, Italy
关键词
D O I
10.1002/jcp.20007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Members of the epidermal growth factor receptor family of receptor tyrosine kinases play a critical role in both development and oncogenesis. The latter is suggested by the frequent overexpression of HER-2, EGFR, and HER-3 in some human carcinomas, primarily breast and squamous cancer. The biological activities of the EGFR family are exerted through various ligand-receptor and receptor-receptor interactions. One receptor that plays a central role in this signaling network is HER-2/Neu, which is considered the preferred heterodimerization partner for other members of the EGFR family. The role of these receptors and their ligands in development is discussed, with particular emphasis on their ability to mediate a variety of pathways and cellular responses, including proliferation, differentiation, and apoptosis. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 80 条
  • [31] ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation
    Jones, FE
    Welte, T
    Fu, XY
    Stern, DF
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 147 (01) : 77 - 87
  • [32] ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
    Karunagaran, D
    Tzahar, E
    Beerli, RR
    Chen, XM
    GrausPorta, D
    Ratzkin, BJ
    Seger, R
    Hynes, NE
    Yarden, Y
    [J]. EMBO JOURNAL, 1996, 15 (02) : 254 - 264
  • [33] Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein
    Kim, HH
    Vijapurkar, U
    Hellyer, NJ
    Bravo, D
    Koland, JG
    [J]. BIOCHEMICAL JOURNAL, 1998, 334 : 189 - 195
  • [34] Kim JY, 2003, J NEUROSCI, V23, P5561
  • [35] Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development
    Kramer, R
    Bucay, N
    Kane, DJ
    Martin, LE
    Tarpley, JE
    Theill, LE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) : 4833 - 4838
  • [36] Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
    Kulik, G
    Klippel, A
    Weber, MJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (03) : 1595 - 1606
  • [37] ErbB2 potentiates breast tumor proliferation through modulation of p27Kip1-Cdk2 complex formation:: Receptor overexpression does not determine growth dependency
    Lane, HA
    Beuvink, I
    Motoyama, AB
    Daly, JM
    Neve, RM
    Hynes, NE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) : 3210 - 3223
  • [38] The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast
    Latta, EK
    Tjan, S
    Parkes, RK
    O'Malley, FP
    [J]. MODERN PATHOLOGY, 2002, 15 (12) : 1318 - 1325
  • [39] Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C α activity
    Le, XF
    Marcelli, M
    McWatters, A
    Nan, BC
    Mills, GB
    O'Brian, CA
    Bast, RC
    [J]. ONCOGENE, 2001, 20 (57) : 8258 - 8269
  • [40] REQUIREMENT FOR NEUREGULIN RECEPTOR ERBB2 IN NEURAL AND CARDIAC DEVELOPMENT
    LEE, KF
    SIMON, H
    CHEN, H
    BATES, B
    HUNG, MC
    HAUSER, C
    [J]. NATURE, 1995, 378 (6555) : 394 - 398